Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06077019

Role of Lung Function for Exercise Capacity in Well-trained Individuals

Role of Lung Function, Airway Inflammation and Bronchial Hyper Reactivity for Exercise Capacity in Well-trained Individuals

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Morten Hostrup, PhD · Academic / Other
Sex
All
Age
18 Years – 39 Years
Healthy volunteers
Accepted

Summary

The purpose of the project is to investigate exercise performance in humans following prolonged inhalation of beta2-agonists vilanterol + fluticasone furoate or indacaterol + mometasone furoate

Conditions

Interventions

TypeNameDescription
DRUGVilanterol and Fluticasone FuroateParticipants inhale 25 µg vilanterol + fluticasone furoate daily
DRUGIndacaterol and Mometasone FuroateParticipants inhale 125 µg indacaterol + mometasone furoate daily
DRUGPlaceboParticipants inhale placebo daily

Timeline

Start date
2023-10-03
Primary completion
2026-07-15
Completion
2026-12-01
First posted
2023-10-11
Last updated
2025-04-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT06077019. Inclusion in this directory is not an endorsement.

Role of Lung Function for Exercise Capacity in Well-trained Individuals (NCT06077019) · Clinical Trials Directory